Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Completed 3 Not yet recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 4 Prostatic Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Breast Neoplasms 3 Advanced Solid Tumor 3 Pancreatic Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Hypoxia 2 Advanced Solid Tumors 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pelvic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Monocytic, Acute 1 Leukemia, Biphenotypic, Acute 1

Interventions

Cisplatin 18 pembrolizumab 12 Paclitaxel 9 Carboplatin 9 Radiotherapy 5 Gemcitabine 4 Fluorodeoxyglucose F18 4 Colposcopy 4 Brachytherapy 4 fludarabine 3 durvalumab 3 Surveys and Questionnaires 3 Radiation 3 Flow Cytometry 3 Cyclophosphamide 3 Biopsy 3 Bevacizumab 3 toripalimab 2 fludarabine phosphate 2 atezolizumab 2 aldesleukin 2 adavosertib 2 Zoledronic Acid 2 Topotecan 2 Nivolumab 2 Neoadjuvant Therapy 2 Microarray Analysis 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Uterine Cervical Neoplasms × Injections × Clear all

NCT02233387 2019-03-08

HX4-cervix

Maastricht Radiation Oncology

Phase 2 Terminated

Hypoxia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡